Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...

Sanofi's investment raises the value of Orano Med to €1.9 billion and gives it a 16% stake in the company, which focuses on the development of radiotherapies based on lead-212, an isotope that ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

Lead the technical development, testing and implementation of advanced Large Language Model (LLM) based projects and related technologies to deliver end-to-end data science and AI products using ...

Investigates found test results from the Indian Forest neighborhood in Montgomery County show lead in tap water exceeds EPA ...

Lead the technical development, testing and implementation of advanced Large Language Model (LLM) based projects and related technologies to deliver end-to-end data science and AI products using ...

constipation, upper respiratory tract infection, limb injury, and insomnia, according to Sanofi. The dupilumab studies were funded by Sanofi and Regeneron, the companies co-developing dupilumab.

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...